APELOA has continuously received a Wind ESG BBB rating, with a comprehensive score of 6.50同壁财经·May 30 at 10:02 AM000739+1.00%
Chinese API Suppliers Pass On Higher Raw Material Costs Arising From Mideast WarYicai·Apr 22 at 03:46 AM603538+3.04%000739+1.00%
Innovative drug concept stocks continue to be strong, with Menovo hitting a 3-day consecutive limit up, followed by Fushine, BHC, Kingchem, APELOA, and WuXi AppTecWallstreetcn·Mar 25 at 08:35 PM510660+0.86%603538+3.04%
APELOA has repurchased a total of 10.06 million shares at a cost of 144 million yuanZhitong·Nov 3, 2025 at 03:39 AM000739+1.00%
APELOA's subsidiary has obtained the drug registration certificate for L-carnitine injectionZhitong·Oct 31, 2025 at 02:55 AM000739+1.00%
APELOA released its performance for the first three quarters, with a net profit attributable to the parent company of 700 million yuan, a decrease of 19.48%Zhitong·Oct 21, 2025 at 04:00 AM000739+1.00%
CRO concept stocks fluctuate and rise, Jiuzhou Pharma hits the limit upZhitong·Sep 24, 2025 at 08:55 PM000739+1.00%603456+1.25%
APELOA: CDMO business is gradually entering a harvest period and is expected to lead the company's performance into a new growth stageZhitong·Sep 1, 2025 at 10:57 PM000739+1.00%
APELOA: As of now, the company has 49 pet medicine projectsZhitong·Aug 14, 2025 at 11:18 PM000739+1.00%
APELOA: The Phase III clinical trial of the Semaglutide project has completed all enrollmentsWallstreetcn·Aug 7, 2025 at 02:52 AM000739+1.00%
Institutions Favor 60 Stocks for the First Time This WeekZhitong·Jul 25, 2025 at 11:19 AM600183+5.56%002320+0.45%
AH shares all rose! The Shanghai Composite Index increased by 0.5%, with innovative drugs active and brokerages rising. The Hang Seng Index rose over 1%, tech stocks generally increased, black commodities rose, and government bonds fellWallstreetcn·Jul 11, 2025 at 03:21 AM6008640.00%000739+1.00%
APELOA: Cefixime capsules have obtained the drug registration certificateZhitong·Jul 3, 2025 at 06:25 AM000739+1.00%
APELOA: Tofacitinib tosylate has received approval for the listing application of chemical raw materialsZhitong·Jun 30, 2025 at 03:22 AM000739+1.00%
APELOA: The application for the listing of Succinic Acid Desvenlafaxine as a chemical raw material drug has been approvedZhitong·Jun 5, 2025 at 04:27 AM000739+1.00%
